Literature DB >> 31916281

lncRNA MSC-AS1 activates Wnt/β-catenin signaling pathway to modulate cell proliferation and migration in kidney renal clear cell carcinoma via miR-3924/WNT5A.

Zhaoxiong Hu1, Linhong Li2, Peng Cheng1, Qin Liu3, Xuan Zheng1, Feng Peng4, Qinghong Zhang1.   

Abstract

Kidney renal clear cell carcinoma (KIRC) is the most general subtype of renal cell carcinoma, which composes about 1/20 of adult malignancies. The anomaly of long noncoding RNAs (lncRNAs) expression is proved to mediate cancer progression of various types. The function and mediation mechanism of MSC-AS1 has rarely been detected in KIRC before. This study started with the mediation of MSC-AS1 on cell function. In this study, MSC-AS1 was dramatically upregulated in KIRC and correlated with dismal prognosis of KIRC patients. Knockdown of MSC-AS1 would suppress the proliferative and migratory properties of KIRC cells. MSC-AS1 was found to directly downregulate miR-3924 expression while miR-3924 directly downregulated WNT5A expression. Meanwhile, MSC-AS1 could promote the expression of WNT5A, indicating the existence of MSC-AS1/miR-3924/WNT5A. Further assays indicated that MSC-AS1 could enhance Wnt/β-catenin pathway. By means of rescue assays, the mediation of MSC-AS1/miR-3924/WNT5A/β-catenin axis on KIRC cell proliferation, migration and migration was verified. This study revealed that MSC-AS1 regulates KIRC cell proliferation and migration via miR-3924/WNT5A/β-catenin axis. MSC-AS1 might contribute to new strategies for KIRC treatment.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  KIRC; MCF-AS1; WNT5A; miR-3924

Mesh:

Substances:

Year:  2020        PMID: 31916281     DOI: 10.1002/jcb.29594

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  20 in total

1.  WNT5A promotes the metastasis of esophageal squamous cell carcinoma by activating the HDAC7/SNAIL signaling pathway.

Authors:  Yingtong Feng; Zhiqiang Ma; Minghong Pan; Liqun Xu; Junjun Feng; Yimeng Zhang; Changjian Shao; Kai Guo; Hongtao Duan; Yujing Zhang; Yuxi Zhang; Jiao Zhang; Di Lu; Xiaoya Ren; Jing Han; Xiaofei Li; Xiaolong Yan
Journal:  Cell Death Dis       Date:  2022-05-20       Impact factor: 9.685

2.  CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines.

Authors:  Alessio Biagioni; Anastasia Chillà; Mario Del Rosso; Gabriella Fibbi; Francesca Scavone; Elena Andreucci; Silvia Peppicelli; Francesca Bianchini; Lido Calorini; Anna Li Santi; Pia Ragno; Francesca Margheri; Anna Laurenzana
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

3.  Identification and Validation of Hub Genes Associated with Bladder Cancer by Integrated Bioinformatics and Experimental Assays.

Authors:  Kang Chen; Ji Xing; Weimin Yu; Yuqi Xia; Yunlong Zhang; Fan Cheng; Ting Rao
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

4.  LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis.

Authors:  Wei Yang; Fusheng Ge; Shuaibing Lu; Zhiming Shan; Liangqun Peng; Junhui Chai; Hongxing Liu; Baodong Li; Zhandong Zhang; Jinxi Huang; Yawei Hua; Yonglei Zhang
Journal:  Front Med (Lausanne)       Date:  2021-12-02

5.  LncRNA-MSC-AS1 inhibits the ovarian cancer progression by targeting miR-425-5p.

Authors:  Yinling Zhao; Xinhua Bu; Donglan Yuan; Dandan Zhu; Tianhui Xu; Aihua Huang; Li Jiang; Chiwen Liu; Hua Qian
Journal:  J Ovarian Res       Date:  2021-08-28       Impact factor: 4.234

6.  LncRNA MSC-AS1 Promotes Colorectal Cancer Progression by Regulating miR-325/TRIM14 Axis.

Authors:  Changhong He; Xia Wang; Meichun Du; Yanjun Dong
Journal:  J Oncol       Date:  2021-05-11       Impact factor: 4.375

7.  MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.

Authors:  Chong Li; Shiyu Feng; Ling Chen
Journal:  Mol Cell Biochem       Date:  2020-10-26       Impact factor: 3.396

8.  Long non-coding RNA SNHG3 promotes the progression of clear cell renal cell carcinoma via regulating BIRC5 expression.

Authors:  Zhaoyu Xu; Junjie Ye; Pengfei Bao; Qi Wu; Fuchen Xie; Peng Li
Journal:  Transl Cancer Res       Date:  2021-10       Impact factor: 1.241

9.  Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy.

Authors:  Zhenfei Xiang; Erdong Shen; Mingyao Li; Danfei Hu; Zhanchun Zhang; Senquan Yu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

10.  Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma.

Authors:  Pengcheng Zhou; Yuhua Lu; Yewei Zhang; Lei Wang
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.